FDA Authorizes Marketing of Automated Insulin Dosing Controller
THURSDAY, Dec. 19, 2019 -- The U.S. Food and Drug Administration recently approved marketing of an interoperable automated glycemic controller device, the Tandem Diabetes Care Control-IQ Technology, the agency announced last week.
The device...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Diabetes | Endocrinology | Food and Drug Administration (FDA) | General Medicine | Insulin | Marketing